SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Regeneron to Present Ordspono Trial Results at ASH

Regeneron plans to present trial results for Ordspono in relapsed or refractory marginal zone lymphoma at ASH.

REGN

Related stories